Bone growth factors.
暂无分享,去创建一个
S. Mohan | D J Baylink | S Mohan | D. Baylink
[1] D. Moscatelli,et al. The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.
[2] E. Froesch,et al. Insulin‐like growth factor I supports differentiation of cultured osteoblast‐like cells , 1984, FEBS letters.
[3] C. Brinckerhoff,et al. Use of agarose culture to measure the effect of transforming growth factor beta and epidermal growth factor on rabbit articular chondrocytes. , 1985, Cancer research.
[4] M. Noda,et al. In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.
[5] L. Raisz,et al. Local and systemic factors in the pathogenesis of osteoporosis. , 1988, World review of nutrition and dietetics.
[6] J. Wallace,et al. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding. , 1988, Biochemical and biophysical research communications.
[7] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[8] K. Miyagawa,et al. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Cuevas,et al. Hypotensive activity of fibroblast growth factor. , 1991, Science.
[10] U. Stenman,et al. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[11] J. Dasch,et al. Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone. , 1992, The Journal of biological chemistry.
[12] D. Rifkin,et al. Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.
[13] A. Balland,et al. Isolation from human cerebrospinal fluid of a new insulin‐like growth factor‐binding protein with a selective affinity for IGF‐II , 1989, FEBS letters.
[14] D. Gospodarowicz,et al. Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.
[15] K. Matsumoto,et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Sahagian,et al. Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. , 1988, The Journal of biological chemistry.
[17] A. Reddi,et al. Affinity of osteogenin, an extracellular bone matrix associated protein initiating bone differentiation, for concanavalin A. , 1989, Biochemical and biophysical research communications.
[18] C. Fombrun,et al. Matrix , 1979, Encyclopedic Dictionary of Archaeology.
[19] J. Wergedal,et al. Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro. , 1982, Biochemistry.
[20] W. Rutter,et al. Insulin-like growth factor II receptor as a multifunctional binding protein , 1987, Nature.
[21] B. Stadler,et al. Production of hemopoietic growth factors by bone tissue and bone cells in culture , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] Darrell M. Wilson,et al. Levels of insulin-like growth factors I and II in human cord blood. , 1983, The Journal of clinical endocrinology and metabolism.
[23] M. Sporn,et al. Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.
[24] G. Rodan,et al. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. , 1986, Biochemical and biophysical research communications.
[25] A. Roberts,et al. Membrane binding characteristics of two forms of transforming growth factor-beta. , 1987, The Journal of biological chemistry.
[26] N. Savion,et al. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone‐like nodules in vitro , 1989, FEBS letters.
[27] M. Sporn,et al. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.
[28] D. Baylink,et al. Purification of a skeletal growth factor from human bone. , 1982, Biochemistry.
[29] B. Olwin,et al. Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. , 1986, Biochemistry.
[30] E. Canalis,et al. Skeletal tissue and transforming growth factor β , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] S. Mohan,et al. Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3‐E1) , 1986, Journal of cellular physiology.
[32] F. D. Di Padova,et al. Interleukin‐6 is produced by bone and modulated by parathyroid hormone , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] E. Canalis,et al. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. , 1989, Endocrinology.
[34] L. Demers,et al. Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Wergedal,et al. Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitro , 1991 .
[36] G. Peters,et al. Potential oncogene product related to growth factors , 1987, Nature.
[37] Y. Ogawa,et al. Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. , 1992, Experimental hematology.
[38] M. Urist,et al. Bone cell differentiation and growth factors. , 1983, Science.
[39] Christopher C. Binkert,et al. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.
[40] E. Wagner,et al. Bone and haematopoietic defects in mice lacking c-fos , 1992, Nature.
[41] M. Hunkapiller,et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. V. Van Wyk,et al. Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. , 1983, Endocrinology.
[43] D. Baylink,et al. In vitro evidence that bone formation may be coupled to resorption by release of mitogen(s) from resorbing bone. , 1987, Metabolism: clinical and experimental.
[44] D. Baylink,et al. Coupling factor. , 1982, Advances in Experimental Medicine and Biology.
[45] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[46] R. Baxter,et al. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. , 1989, The Journal of biological chemistry.
[47] M. Rechler,et al. The nature and regulation of the receptors for insulin-like growth factors. , 1985, Annual review of physiology.
[48] H. Marquardt,et al. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide , 1988, Molecular and cellular biology.
[49] A. Roberts,et al. Purification and properties of a type beta transforming growth factor from bovine kidney. , 1983, Biochemistry.
[50] S. Mohan,et al. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[51] P. Campbell,et al. Insulin‐Like growth factor binding protein (IGFBP) inhibits igf action on human osteosarcoma cells , 1991, Journal of cellular physiology.
[52] M. Goldfarb,et al. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors , 1988, Molecular and cellular biology.
[53] S. Mohan,et al. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[54] G. Mundy,et al. Effects of human recombinant CSF‐GM and highly purified CSF‐1 on the formation of multinucleated cells with osteoclast characteristics in long‐term bone marrow cultures , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] J. Schwander,et al. Insulin-Like Growth Factor-Binding Protein , 1989, Definitions.
[56] J. Graycar,et al. Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta. , 1987, The Journal of biological chemistry.
[57] G. Wesolowski,et al. Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. , 1987, Endocrinology.
[58] A. Reddi,et al. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[59] E. Canalis,et al. Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae. , 1988, Endocrinology.
[60] V. Rosen,et al. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. , 1989, Connective tissue research.
[61] E. Canalis,et al. Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.
[62] J. Massagué,et al. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. , 1986, Endocrinology.
[63] S. Mohan,et al. Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. , 1990, Growth factors.
[64] P. Cuevas,et al. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. , 1988, Biochemical and biophysical research communications.
[65] E. Canalis. Insulin like growth factors and the local regulation of bone formation. , 1992, Bone.
[66] G. Mundy,et al. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice , 1990 .
[67] S. Mohan,et al. Characterization of the receptor for insulin‐like growth factor II in bone cells , 1989, Journal of cellular physiology.
[68] H. Oppermann,et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.
[69] G. Rodan,et al. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. , 1990, Endocrinology.
[70] M. Hammerman,et al. Insulin-like growth factors and aging. , 1987, Endocrinology and metabolism clinics of North America.
[71] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988, Science.
[72] R. Furlanetto,et al. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. , 1987, The Journal of clinical endocrinology and metabolism.
[73] T. C. B. STAMP,et al. Mineral metabolism , 1974, Nature.
[74] S. Mohan. A simple and efficient scheme for the purification of insulin-like growth factor II from human bone matrix extract. , 1990, Growth factors.
[75] R. Roth. Structure of the receptor for insulin-like growth factor II: the puzzle amplified. , 1988, Science.
[76] D. Clemmons,et al. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[77] Mark E. Bolander,et al. Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[78] C. Osborne,et al. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. , 1989, The Journal of clinical investigation.
[79] J. Wergedal,et al. Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. , 1975, Endocrinology.
[80] M. Ranke,et al. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.
[81] W. Hazzard,et al. Principles of geriatric medicine , 1985 .
[82] E. Canalis,et al. Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Ross,et al. The biology of platelet-derived growth factor , 1986, Cell.
[84] E. Drier,et al. OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.
[85] M. O’Connor-McCourt,et al. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.
[86] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988 .
[87] D. Baylink,et al. Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. , 1981, Metabolic bone disease & related research.
[88] D. Andress,et al. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.
[89] E. Canalis,et al. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.
[90] S. Mohan,et al. Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. , 1989, Biochemical and biophysical research communications.
[91] S. Mohan,et al. Chemical and biological characterization of low-molecular-weight human skeletal growth factor. , 1986, Biochimica et biophysica acta.
[92] B. Riggs,et al. Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone , 1991 .
[93] K. Nakashima,et al. Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes. , 1991, The Journal of biological chemistry.
[94] S. Mohan,et al. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. , 1989, Endocrinology.
[95] P. ten Dijke,et al. Identification of another member of the transforming growth factor type beta gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[96] R. Hintz,et al. Somatomedin Receptors: Structure, Function, and Regulation , 1986 .
[97] K. Hall,et al. The somatomedin-binding protein isolated from a human hepatoma cell line is identical to the human amniotic fluid somatomedin-binding protein. , 1985, Biochemical and biophysical research communications.
[98] D. Gospodarowicz. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth , 1974, Nature.
[99] K. Thomas,et al. Purification and characterization of acidic fibroblast growth factor from bovine brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[100] S. Mohan,et al. Characterization of mitogenic activities extracted from bovine bone matrix. , 1986, Bone.
[101] G. Howard,et al. Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[102] J. Wergedal,et al. Differentiation of normal human bone cells by transforming growth factor-beta and 1,25(OH)2 vitamin D3. , 1992, Metabolism: clinical and experimental.
[103] J. McPherson,et al. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. , 1986, The Journal of biological chemistry.
[104] D. Donoghue,et al. Structure and function of platelet-derived growth factor (PDGF) and related proteins. , 1989, Biochimica et biophysica acta.
[105] J. Massagué,et al. Multiple type-beta transforming growth factors and their receptors. , 1987, Journal of cellular physiology. Supplement.
[106] M. Klagsbrun,et al. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.
[107] P. Segarini,et al. Purification and characterization of a unique osteoinductive factor from bovine bone. , 1989, The Journal of biological chemistry.
[108] Y. Ohmori,et al. Human purified interleukin‐1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3‐E1), but enhances alkaline phosphatase activity in the cells , 1986, FEBS letters.
[109] E. Froesch,et al. Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. , 1989, Biochemical and biophysical research communications.
[110] G. Mundy,et al. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[111] A. Ullrich,et al. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. , 1988, Science.
[112] William C. Smith,et al. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos , 1992, Cell.
[113] R. Palmiter,et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.
[114] D. Gospodarowicz,et al. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. , 1988, Endocrinology.
[115] G. Wesolowski,et al. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. , 1989, The Journal of biological chemistry.
[116] M. Hayman,et al. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[117] G. Ooi,et al. The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. , 1988, The Journal of endocrinology.
[118] L. Donahue,et al. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. , 1992, The Journal of clinical endocrinology and metabolism.
[119] R. Kamen,et al. The human hematopoietic colony-stimulating factors. , 1987, Science.
[120] K. Mitchell,et al. Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[121] S. Mohan,et al. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[122] S. Mohan,et al. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. , 1990, Endocrinology.
[123] D. Rowe,et al. Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. , 1989, Endocrinology.
[124] N. Ling,et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[125] S. Mohan,et al. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins. , 1990, Endocrinology.
[126] S. Ljunghall,et al. Insulin-like growth factor I stimulates bone turnover in osteoporosis , 1992, The Lancet.
[127] A. Moses,et al. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[128] D. Gospodarowicz,et al. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. , 1985, The Journal of biological chemistry.
[129] A. Reddi,et al. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. , 1992, Plastic and reconstructive surgery.
[130] Sporn,et al. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.
[131] J. Irminger,et al. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[132] R. Voutilainen,et al. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. , 1988, Endocrinology.
[133] A. Reddi,et al. Dissociative extraction and partial purification of osteogenin, a bone inductive protein, from rat tooth matrix by heparin affinity chromatography. , 1988, Biochemical and biophysical research communications.
[134] M. Sporn,et al. Purification and initial characterization of a type beta transforming growth factor from human placenta. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[135] D. Moscatelli,et al. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.
[136] E. Rinderknecht,et al. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[137] B. Olwin,et al. Identification of a cysteine-rich receptor for fibroblast growth factors , 1992, Molecular and cellular biology.
[138] J. Lian,et al. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. , 1988, Bone.
[139] J. Rubin,et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. , 1989, Science.
[140] M. Sporn,et al. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. , 1988, Molecular endocrinology.
[141] R. Baxter,et al. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.
[142] E. Froesch,et al. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. , 1986, Hormone research.
[143] G. Howard,et al. Extracts of bone contain a potent regulator of bone formation. , 1982, Biochimica et biophysica acta.
[144] S. Handwerger,et al. Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts , 1983, Nature.
[145] D. Rosen,et al. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[146] Y. Ohmori,et al. Spontaneous production of interleukin-1-like cytokine from a mouse osteoblastic cell line (MC3T3-E1). , 1985, Biochemical and biophysical research communications.
[147] S. Mohan,et al. Beta 2-microglobulin is not a bone cell mitogen. , 1989, Endocrinology.
[148] S. Mohan,et al. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. , 1991, Biochemical and biophysical research communications.
[149] W. Wood,et al. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. , 1988, Molecular endocrinology.
[150] E. Mackie,et al. Stimulation of bone formation in vivo by transforming growth factor-beta: remodeling of woven bone and lack of inhibition by indomethacin. , 1990, Bone.
[151] C Collins,et al. Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.
[152] S. Mohan,et al. Comparison of the biological actions of TGF beta‐1 and TGF beta‐2: Differential activity in endothelial cells , 1988, Journal of cellular physiology.
[153] J. Heath,et al. Developmentally regulated expression of insulin-like growth factors by differentiated murine teratocarcinomas and extraembryonic mesoderm. , 1986, Journal of embryology and experimental morphology.
[154] A. König,et al. Tumor necrosis factor α and interleukin‐1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice , 1988 .
[155] G. Smith,et al. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[156] H. Armelin. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[157] I. Nishimoto,et al. Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system. , 1988, Biochemical and biophysical research communications.
[158] S. Mohan,et al. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. , 1990, The Journal of clinical endocrinology and metabolism.
[159] A. Lindahl,et al. Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. , 1986, The American journal of physiology.
[160] M. Czech,et al. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. , 1986, The Journal of biological chemistry.
[161] A. Efstratiadis,et al. Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.
[162] V. Rosen,et al. Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[163] J. Sussenbach. The gene structure of the insulin-like growth factor family. , 1989, Progress in growth factor research.
[164] S. Mohan,et al. Skeletal growth factor is produced by human osteoblast-like cells in culture. , 1986, Biochimica et biophysica acta.
[165] D. Birnbaum,et al. Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. , 1989, Oncogene.
[166] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[167] E. Chen,et al. The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.
[168] D. B. Evans,et al. The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells. , 1989, Biochemical and biophysical research communications.
[169] M E Bolander,et al. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.
[170] G. Rodan,et al. Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells , 1986 .
[171] Birgitta,et al. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. , 1987, The Journal of biological chemistry.
[172] S. Mohan,et al. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. , 1990, Metabolism: clinical and experimental.
[173] M. Urist. Bone: Formation by Autoinduction , 1965, Science.
[174] E. Canalis,et al. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. , 1989, Endocrinology.
[175] J. Puzas,et al. Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes. , 1988, Endocrinology.
[176] P. Schnegelsberg,et al. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. , 1992, The Journal of biological chemistry.
[177] G. Howard,et al. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. , 1991, Bone.
[178] E. Canalis,et al. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. , 1988, Endocrinology.
[179] P. Rotwein,et al. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[180] R. Derynck,et al. Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[181] S. Bell,et al. N-terminal amino acid sequence of human pregnancy-associated endometrial alpha 1-globulin, an endometrial insulin-like growth factor (IGF) binding protein--evidence for two small molecular weight IGF binding proteins. , 1988, Endocrinology.
[182] H. Antoniades,et al. Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. , 1982, Endocrinology.
[183] D. B. Evans,et al. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. , 1991, The Journal of biological chemistry.
[184] D. Moscatelli,et al. Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[185] N. Copeland,et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily , 1992, Cell.
[186] E. Froesch,et al. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.